Efficacy News and Research

RSS
Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Patient recruitment complete in Kuros' KUR-023 dural sealant European clinical trial

Study finds broadest immune response from LAIV nasal spray vaccines for children

Study finds broadest immune response from LAIV nasal spray vaccines for children

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

LYSOGENE launches the first gene therapy clinical trials in Sanfilippo disease

Study explores how some cognitive strategies and abilities boost self-efficacy

Study explores how some cognitive strategies and abilities boost self-efficacy

Combination immunotherapy more effective for patients with Sezary Syndrome

Combination immunotherapy more effective for patients with Sezary Syndrome

AVI BioPharma, MDA to initiate exon-51 Phase 2 trial in Duchenne muscular dystrophy

AVI BioPharma, MDA to initiate exon-51 Phase 2 trial in Duchenne muscular dystrophy

Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia

Enrollment commences in Omthera's Epanova Phase III trial for hypertriglyceridemia

Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome

Enrollment commences in RegeneRx RGN-259 Phase 2 trial for dry eye syndrome

Starpharma starts bacterial vaginosis prevention study of VivaGel

Starpharma starts bacterial vaginosis prevention study of VivaGel

Fibrate drugs may not prevent heart attacks in diabetes patients with elevated cholesterol

Fibrate drugs may not prevent heart attacks in diabetes patients with elevated cholesterol

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

Study confirms ability of Tru-D device to decontaminate surfaces in patient rooms

Study confirms ability of Tru-D device to decontaminate surfaces in patient rooms

CPAP withdrawal leads to return of obstructive sleep apnea

CPAP withdrawal leads to return of obstructive sleep apnea

FDA assigns PDUFA action date for review of Affymax peginesatide NDA

FDA assigns PDUFA action date for review of Affymax peginesatide NDA

Pacira second quarter total revenues increase to $3.6 million

Pacira second quarter total revenues increase to $3.6 million

Researchers identify unknown link between migration of WBCs to infected tissues, immune memory

Researchers identify unknown link between migration of WBCs to infected tissues, immune memory

Anticoagulation service improves quality of care for patients treated with warfarin

Anticoagulation service improves quality of care for patients treated with warfarin

FDA approves Gilead's Complera for treatment of HIV-1 infection

FDA approves Gilead's Complera for treatment of HIV-1 infection

Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV

Aeras, OETC announce initiation of new TB vaccine Phase IIb trial in patients with HIV

BELLUS Health second quarter revenues increase to $719,000

BELLUS Health second quarter revenues increase to $719,000

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.